Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial.

Low PA, Robertson D, Gilman S, Kaufmann H, Singer W, Biaggioni I, Freeman R, Perlman S, Hauser RA, Cheshire W, Lessig S, Vernino S, Mandrekar J, Dupont WD, Chelimsky T, Galpern WR
Lancet Neurol. 2014 13 (3): 268-75

PMID: 24507091 · PMCID: PMC4030757 · DOI:10.1016/S1474-4422(13)70301-6

MeSH Terms (12)

Aged Cohort Studies Double-Blind Method Female Follow-Up Studies Humans Male Middle Aged Multiple System Atrophy Nucleic Acid Synthesis Inhibitors Rifampin Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: